SWOG Cancer Research Network

EXCITED for the @SWOG spring meeting, thanks to @SupportingSWOG! Starting things off w/ the #Palliative committee! #oncology #nurse #nursepractitioner #research #scientist

Departing from my favorite airport @flyPSP to San Francisco for @SWOG #SWOGSpring26! Excited to see some of my favorite folks & talk all things #oncology & #clinicaltrials! #patientadvocate

Excited to see this highlighted 👇 The gut microbiome may play a meaningful role in kidney cancer outcomes—and we’re now testing this prospectively in the BIOFRONT (S2419) trial. A simple oral intervention (CBM588) + immunotherapy → could reshape how we think about treatment. @UHhospitals @SWOG @montypal @DrVaishampayan @caseccc #KidneyCancer #Oncology #Immunotherapy #Microbiome cleveland.com/medical/2026/0…

Composition of Health Care Contact Days and Mortality Prediction Among Older Adult Clinical Trial Participants. Co-authored by @guptaarjun90, @SWOG, @DrDawnHershman and @DrJoeUnger. Read the full article. bit.ly/4tALDUj

10-Abstract LBA 5003: SWOG S1823 interim analysis; miR371 continues to be explored as a biomarker for detecting active germ cell malignancy in early-stage testicular cancer. @bccancerfdn @ASCO @OncoAlert

Thrilled and proud that our Section Chief Dr. @SoniSmithMD has been selected as the Chair of @SWOG's lymphoma committee!! She is an incredible leader and very much deserves this honor!

Honored to be invited to do Grand Rounds on RCC at CWRU Cleveland OH. Coincided with activation of SWOG Biofront trial S 2419 ⁦@SWOG⁩ @HOPE foundation

.@SWOG S2213 Ph3 RCT Dara-VC Induction Followed by ASCT or Dara-VCD Consolidation & Daratumumab Maintenance in Pts w/ Newly Diagnosed AL Amyloidosis [Activated: 12/1/23] swog.org/clinical-trial… #mmsm #bmtsm

Incredibly proud to share this work with @ToniRibas12 Thank you to all collaborators and support @parkerici @SWOG @SU2C @Agilent @Covaris @AACR @UCLAJCCC

What can we learn from the @SWOG Pragmatica-Lung study that can help us activate and enroll studies more quickly? Listen as SWOG lung committee chair @JhanelleGray and our co-hosts @RyanNguyenDO and @Omene_CO discuss this important study. 🎧 Listen now: bridgingthegap.riverside.com/e/pragmatic-cl…

Absolutely right, @barbarasegarra: @SWOG patient advocates do rock! So grateful for your contributions to patient-centering our clinical trials.

The @SWOG patient advocates are well represented at @AACR annual mtg as a part of the Scientist <-> Survivor program! We are here to learn & bring back information we learn to our communities! It’s also pretty amazing to see trials we helped with be presented! #AACR26 #AACRSSP

"@LungMAP is the most transformative & pivotal trial in the MET Crusaders right now." Hear MET Crusaders Chair Marcia K. Horn, JD, on 3 current @LungMAP studies for patients with advanced #NSCLC with MET biomarkers. @metcrusaders #lcsm #ClinicalTrials youtube.com/watch?v=H1mxk7…

.@SWOG S2213 Ph3 RCT Dara-VC Induction Followed by ASCT or Dara-VCD Consolidation & Daratumumab Maintenance in Pts w/ Newly Diagnosed AL Amyloidosis [Activated: 12/1/23] swog.org/clinical-trial… #mmsm #bmtsm

Thanks to @SyedAAhmad5 for highlighting! This is the largest rare cancer trial ever conducted! Thanks to @PatelOncology, @youngkwangchae, @Dr_R_Kurzrock, @SWOG, @theNCI, @eaonc, @NRGonc, & @ALLIANCE_org!

Our DART S1609 🧪 signaled activity for dual CTLA-4/PD-1 across 53 rare cancers • 1,000+ sites 🇺🇸 | 727 pts in ~6 yrs • ~50% cohorts showed activity (≥2 responses) • >10% had durable benefit ⏳ (PFS ≥2 yrs by iRECIST) @SWOG @OncoAlert @LurieCancer tinyurl.com/3xrhdcd8

@SWOG S1609 DART (nivo/ipi) across rare tumors published in @Annals_Oncology @Dr_R_Kurzrock @youngkwangchae @NCIDirector @theNCI annalsofoncology.org/article/S0923-…

.@SWOG S2213 Ph3 RCT Dara-VC Induction Followed by ASCT or Dara-VCD Consolidation & Daratumumab Maintenance in Pts w/ Newly Diagnosed AL Amyloidosis [Activated: 12/1/23] swog.org/clinical-trial… #mmsm #bmtsm

😀to join my colleagues in 🗣️the importance of surgical oncology participation in #NCTN coop groups. Only by working together with our fellow 🦀 specialists will we move the 🪡 forward for the benefit of our pts. @OHSUKnight @SWOG @eaonc @ALLIANCE_org @NRGonc @CDNCancerTrials

The S2409 PRISM #ClinicalTrial asks if we can treat extensive stage small cell lung cancer more effectively by targeting the vulnerabilities of specific molecular subtypes of the disease. #SCLC #LCSM PI: @AnneChiangMD @YaleCancer swog.org/clinical-trial… @LaurenByersMD @BadiyanMD